Jeff Yass’s Revelation Biosciences REVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.5K Buy
+2,704
New +$19.4K ﹤0.01% 13172
2024
Q4
– Sell
-10
Closed -$11.3K – 13041
2024
Q3
$11.3K Buy
+10
New +$16.9K ﹤0.01% 11709
2023
Q4
– Hold
0
– -$8.56K – 13153
2023
Q3
– Hold
0
– – – 11736
2021
Q4
– Hold
0
– -$126K – 13770
2021
Q3
– Hold
0
– – – 11916

Other funds holding REVB

Jeff Yass's REVB Position: Q3 2026 in Review

Jeff Yass opened a new position in Revelation Biosciences (REVB) in Q3 2026: 2,704 shares worth $15.5K. The stake represents ﹤0.01% of the portfolio and ranks #13172 among its holdings. This is a return to the name: Jeff Yass previously reported a position in REVB as recently as Q3 2024.

Jeff Yass first reported a position in REVB in Q3 2024 and has held it in 2 quarters since. 12 funds tracked by Wall St. Rank hold REVB as of Q3 2026.

  • Jeff Yass held 2,704 shares of Revelation Biosciences worth $15.5K as of Q3 2026.
  • Revelation Biosciences was a new Jeff Yass position in Q3 2026.
  • Revelation Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13172 holding.
  • Jeff Yass first reported a position in Revelation Biosciences in Q3 2024 and has held it in 2 quarters since.
  • 12 funds tracked by Wall St. Rank held Revelation Biosciences as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.